SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Upexi, Inc. (UPXI) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -204.05%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+316.7%).
- Trailing Earnings Yield -204.05% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
- Analyst consensus target $5.00 (+316.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UPXI
Valuation Multiples
P/E (TTM)-0.5
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.24
P/S Ratio2.78
EV/EBITDA5.5
Per Share Data
EPS (TTM)$-2.02
Book Value / Share$0.80
Revenue / Share$0.41
FCF / Share$-0.29
Yields & Fair Value
Earnings Yield-204.05%
Dividend Yield0.00%
Analyst Target$5.00 (+316.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-2,773.7 |
0.00 |
343.41 |
737.44 |
- |
| 2020 |
-302.5 |
-0.33 |
7,218.26 |
219.66 |
- |
| 2021 |
24.8 |
-0.02 |
3.48 |
3.06 |
- |
| 2022 |
-648.7 |
6.32 |
47.43 |
59.09 |
- |
| 2023 |
-47.5 |
0.00 |
28.39 |
22.08 |
- |
| 2024 |
-0.3 |
-0.01 |
1.20 |
0.30 |
- |
| 2025 |
-1.7 |
0.02 |
0.26 |
1.49 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.04 |
$2.21M |
$-585.03K |
-26.5% |
| 2020 |
$-0.41 |
$7.41M |
$-5.93M |
-80% |
| 2021 |
$0.19 |
$24.1M |
$2.98M |
12.4% |
| 2022 |
$-0.13 |
$44.58M |
$-2.05M |
-4.6% |
| 2023 |
$-18.94 |
$36.44M |
$-16.93M |
-46.5% |
| 2024 |
$-23.03 |
$26M |
$-23.66M |
-91% |
| 2025 |
$-1.73 |
$15.81M |
$-13.68M |
-86.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-1.08 |
$-1.22 – $-0.94 |
$25.65M |
$23.09M – $28.21M |
1 |
| 2027 |
$-0.29 |
$-0.51 – $-0.06 |
$25.28M |
$20.52M – $30.04M |
2 |
